Hironobu Suto

14PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical infection agents (incl. prions)Wastewater treatment processesNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 10, 2026
Preoperative Prediction of Pathologic Response After Neoadjuvant Chemoradiotherapy for Pancreatic Ductal Adenocarcinoma: A Metabolic Response-Based Predictive Model.

|Jun 22, 2026
Paired tumor-normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancer.

|May 26, 2026
Robotic distal pancreatectomy has a lower incidence than open surgery of clinically relevant pancreatic fistula: a propensity score-matched analysis with emphasis on inflammation and microbial contamination.

|Apr 03, 2026
Outcomes of Spiral Versus Conventional Double Pigtail Plastic Stents in Permanent Transpapillary Gallbladder Drainage for Acute Cholecystitis.

Kiyoyuki Kobayashi, Yu Hidaka, Hideki Kamada

|Dec 27, 2025
ASO Visual Abstract: A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Hironobu Suto, Minoru Oshima, Yasuhisa Ando

|Nov 18, 2025
A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Hironobu Suto, Minoru Oshima, Yasuhisa Ando

Pageof 3

Frequent Collaborators

3 joint publications

Keiichi Okano

2 joint publications

Sohei Satoi

2 joint publications

Yasuhisa Ando

2 joint publications

Hideki Kamada